Cancer Diagnostics Market by IndustryARC

Cancer Diagnostics Market By Materials, By Product, By Preparation Method, By Application and By Geography Analysis - Forecast 2019 - 2024 www.industryarc.com

Cancer Diagnostics Market 2019-2024

sales@industryarc.com

Industry Market Research for Business Leaders, Strategists, Decision Makers

Press Release

Rising incidences of cancer worldwide, technological advancements in oncological diagnostic techniques, and increasing demand for effective screening tests are some of the major factors propelling demand in the cancer diagnostics market, according to a study by IndustryARC. The report estimated the global cancer diagnostics market to have been valued at $135 billion in 2018, and projects it to increase at a CAGR of 6.2% during the forecast period 2019 to 2025.

The report titled, ‘Cancer Diagnostics Market: By Product Type (Next-generation Sequencing, Microarrays, PCR, Flow Cytometry, In situ Hybridization, Others), Cancer Type (Breast, Ovarian, Thyroid, Kidney, Blood, Prostate, Others) & By Geography – Forecast (2019 - 2025)’, describes imperative aspects of the industry including market drivers, market value chain, restraints, growth indicators, market trends, challenges, future outlook, and market insights. Cancer Diagnostics Market: Leading Segments In the global cancer diagnostics market, North America registered the highest share of demand at 37% in 2018. Growing usage of latest technologies for treatment, rising awareness pertaining to cancer treatment, and increase in the reported incidences of cancer coupled with easy access to highly developed healthcare infrastructure contribute to North America’s dominance in the global cancer diagnostics market. According to the National Cancer Institute, breast cancer is not only the most diagnosed type of cancer among women, it is also the most common cancer diagnosed for both genders. Key market players are thus capitalizing on this application segment, which is expected to grow at a CAGR of 28% through to 2025. Cancer Diagnostics Market Disruptive Trends Some of the latest disruptive trends are listed below: ·

Cancer Diagnostics Augmented by Artificial Intelligence and Machine Learning:

Ongoing research pertaining to use of machine learning and natural language processing to create targeted cancer treatments, pair machine learning with computer vision, help identify tumour progression, and creating algorithms that help scientists understand how cancer develops and how to fight them is expected to boost demand for the cancer diagnostics market. ·

Nanotechnology for Cancer Diagnostics:

Nanoscale devices are 100 to 10000 times smaller than human cells, which enable them to gain access to inconspicuous areas of the body in order to detect diseases and facilitate new ways of treatment. ·

CAR-T cell therapy:

Cancer Diagnostics Market

Chimeric Antigen Receptor Therapy (CAR-T) cell therapy, a type of immunotherapy, is one of the most promising advancements in the healthcare industry. It isolates and extracts a patient’s own T-cells, and reengineers those cells with new proteins that recognize and destroy cancer cells once they’re reinfused back into the patient’s body. ·

Advanced Blood Test:

Liquid biopsies assess mutations and other changes in DNA from tumor cells in the blood, and thus provide insight during early stages of cancer. This non-invasive cancer test continues to show promise as a tool for routine cancer screenings and as a potential alternative to tumor biopsy.

Cancer Diagnostics Market: Competitive Landscape Some of the key companies identified in the report that are currently holding majority share in the global cancer diagnostics market are: BioMark Diagnostics Inc., Biotheranostics, Inc., Cancer Diagnostics, Inc., Arquer Diagnostics Ltd, Agilent Technologies, Inc., Becton, Dickinson and Company, GE Healthcare, QIAGEN N.V., Thermo Fisher Scientific, Inc., and Illumina, Inc.

Talk to one of our sales representative about the full report by providing your details in the link below: https://industryarc.com/support.php?id=15739

Related Reports: A.

Cancer Hormone Therapy Market

https://industryarc.com/Report/15740/cancer-hormone-therapy-market.html B.

Cancer Testing/Screening Market

https://industryarc.com/Report/15062/cancer-testing-screening-market.html

What can you expect from the report? The cancer diagnostics market report is prepared with the main agenda to cover the following 20 points:

1. Market Size by Product Categories & Application (Revenue & Cancer Diagnostics Market

11. Demand Analysis Volume) 03

2. Market trends & Relevant Market Data

12. Country level Analysis

3. Manufacturer Landscape

13. Competitor Analysis

4. Distributor Landscape

14. Market Shares Analysis

5. Pricing Analysis

15. Value Chain Analysis

6. Top 10 End user Analysis

16. Supply Chain Analysis

7. Product Benchmarking

17. Strategic Analysis

8. Product Developments Landscape 9. Mergers & Acquisition Analysis

18. Current & Future Market Analysis 19. Opportunity Analysis

10. Patent Analysis Analysis

20. Revenue and Volume

Frequently Asked Questions: Q. Does IndustryARC provide customized reports and charge additionally for limited customization? Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization: 1. Increase the level of data in application or end user industry. 2. Increase the number of countries in geography chapter. 3. Find out market shares for other smaller companies or companies which are of interest to you. 4. Company profiles can be requested based on your interest. 5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

To request for a proposal, provide your details in the below link: https://industryarc.com/reports/request-quote?id=15739

Media Contact:

Cancer Diagnostics Market

Mr. Venkat Reddy Sales Manager Email 1: sales@industryarc.com Or Email 2: venkat@industryarc.com Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.

Cancer Diagnostics Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

Table of Contents 1. Cancer Diagnostics Market - Overview 1.1. Definitions and Scope 2. Cancer Diagnostics Market - Executive summary 2.1. Market Revenue, Market Size and Key Trends by Company 2.2. Key Trends by type of Application 2.3. Key Trends segmented by Geography 3. Cancer Diagnostics Market 3.1. Comparative analysis 3.1.1. Product Benchmarking - Top 10 companies 3.1.2. Top 5 Financials Analysis 3.1.3. Market Value split by Top 10 companies 3.1.4. Patent Analysis - Top 10 companies 3.1.5. Pricing Analysis 4. Cancer Diagnostics Market – Startup companies Scenario 4.1. Top 10 startup company Analysis by 4.1.1. Investment 4.1.2. Revenue 4.1.3. Market Shares 4.1.4. Market Size and Application Analysis 4.1.5. Venture Capital and Funding Scenario 5. Cancer Diagnostics Market – Industry Market Entry Scenario 5.1. Regulatory Framework Overview 5.2. New Business and Ease of Doing business index 5.3. Case studies of successful ventures 5.4. Customer Analysis – Top 10 companies 6. Cancer Diagnostics Market Forces 6.1. Drivers 6.2. Constraints 6.3. Challenges 6.4. Porters five force model 6.4.1. Bargaining power of suppliers 6.4.2. Bargaining powers of customers 6.4.3. Threat of new entrants 6.4.4. Rivalry among existing players 6.4.5. Threat of substitutes 7. Cancer Diagnostics Market -Strategic analysis 7.1. Value chain analysis 7.2. Opportunities analysis 7.3. Product life cycle 7.4. Suppliers and distributors Market Share 8. Cancer Diagnostics Market – By Product Type (Market Size -$Million / $Billion) 8.1. Market Size and Market Share Analysis 8.2. Application Revenue and Trend Research 8.3. Product Segment Analysis 8.3.1. Next-generation Sequencing 8.3.2. Microarrays 8.3.3. PCR 8.3.4. Flow Cytometry 8.3.5. In situ Hybridization

Cancer Diagnostics Market

8.3.6. Immunohistochemistry 8.3.7. Imaging Instruments (MRI, CT, PET, Ultrasound, Mammography) 8.3.8. Biopsy 9. Cancer Diagnostics Market â&#x20AC;&#x201C; By Cancer Treated (Market Size -$Million / $Billion) 9.1. Breast Cancer 9.2. Prostate Cancer 9.3. Ovarian Cancer 9.4. Thyroid Cancer 9.5. Kidney Cancer 9.6. Blood Cancer 9.7. Colorectal Cancer 9.8. Liver Cancer 9.9. Pancreatic Cancer 9.10. Others 10. Cancer Diagnostics - By Geography (Market Size -$Million / $Billion) 10.1. Cancer Diagnostics Market - North America Segment Research 10.2. North America Market Research (Million / $Billion) 10.2.1. Segment type Size and Market Size Analysis 10.2.2. Revenue and Trends 10.2.3. Application Revenue and Trends by type of Application 10.2.4. Company Revenue and Product Analysis 10.2.5. North America Product type and Application Market Size 10.2.5.1. U.S. 10.2.5.2. Canada 10.2.5.3. Mexico 10.2.5.4. Rest of North America 10.3. Cancer Diagnostics - South America Segment Research 10.4. South America Market Research (Market Size -$Million / $Billion) 10.4.1. Segment type Size and Market Size Analysis 10.4.2. Revenue and Trends 10.4.3. Application Revenue and Trends by type of Application 10.4.4. Company Revenue and Product Analysis 10.4.5. South America Product type and Application Market Size 10.4.5.1. Brazil 10.4.5.2. Venezuela 10.4.5.3. Argentina 10.4.5.4. Ecuador 10.4.5.5. Peru 10.4.5.6. Colombia 10.4.5.7. Costa Rica 10.4.5.8. Rest of South America 10.5. Cancer Diagnostics - Europe Segment Research 10.6. Europe Market Research (Market Size -$Million / $Billion) 10.6.1. Segment type Size and Market Size Analysis 10.6.2. Revenue and Trends 10.6.3. Application Revenue and Trends by type of Application 10.6.4. Company Revenue and Product Analysis 10.6.5. Europe Segment Product type and Application Market Size 10.6.5.1. U.K 10.6.5.2. Germany 10.6.5.3. Italy 10.6.5.4. France 10.6.5.5. Netherlands 10.6.5.6. Belgium 10.6.5.7. Spain 10.6.5.8. Denmark 10.6.5.9. Rest of Europe 10.7. Cancer Diagnostics â&#x20AC;&#x201C; APAC Segment Research

Cancer Diagnostics Market

10.8. APAC Market Research (Market Size -$Million / $Billion) 10.8.1. Segment type Size and Market Size Analysis 10.8.2. Revenue and Trends 10.8.3. Application Revenue and Trends by type of Application 10.8.4. Company Revenue and Product Analysis 10.8.5. APAC Segment – Product type and Application Market Size 10.8.5.1. China 10.8.5.2. Australia 10.8.5.3. Japan 10.8.5.4. South Korea 10.8.5.5. India 10.8.5.6. Taiwan 10.8.5.7. Malaysia 11. Cancer Diagnostics Market - Entropy 11.1. New product launches 11.2. M&A's, collaborations, JVs and partnerships 12. Cancer Diagnostics Market – Industry / Segment Competition landscape 12.1. Market Share Analysis 12.1.1. Market Share by Country- Top companies 12.1.2. Market Share by Region- Top 10 companies 12.1.3. Market Share by type of Application – Top 10 companies 12.1.4. Market Share by type of Product / Product category- Top 10 companies 12.1.5. Market Share at global level- Top 10 companies 12.1.6. Best Practises for companies 13. Cancer Diagnostics Market – Key Company List by Country 14. Cancer Diagnostics Market Company Analysis 14.1. Market Share, Company Revenue, Products, M&A, Developments 14.2. Thermo Fisher Scientific, Inc. 14.3. GE Healthcare (A Subsidiary of General Electric Company) 14.4. Abbott Laboratories, Inc. 14.5. Becton, Dickinson and Company 14.6. Siemens Healthcare 14.7. Agilent Technologies, Inc. 14.8. Roche 14.9. C.R. Bard, Inc. 14.10. Illumina, Inc. 14.11. Boehringer-Ingelheim 14.12. Company 11 14.13. Company 12 14.14. Company 13 and more "*Financials would be provided on a best efforts basis for private companies" 15. Cancer Diagnostics Market -Appendix 15.1. Abbreviations 15.2. Sources 16. Cancer Diagnostics Market -Methodology 16.1. Research Methodology 16.1.1. Company Expert Interviews 16.1.2. Industry Databases 16.1.3. Associations 16.1.4. Company News 16.1.5. Company Annual Reports 16.1.6. Application Trends 16.1.7. New Products and Product database 16.1.8. Company Transcripts 16.1.9. R&D Trends 16.1.10. Key Opinion Leaders Interviews 16.1.11. Supply and Demand Trends

Cancer Diagnostics Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

IndustryARC Solutions We cater to the pain points of our clients by providing the following solutions, which are targeted and address key issues specifically. Each of the business verticals is helpful to a client at various stages of their operational, managerial and strategic level plans. Syndicate Reports and Consulting (SRC) 1. Provide high quality analytical syndicated reports with key market insights, strategies and market forecasts for a specific industry or vertical of the clients. Constant tracking of industries and relations with experts helps us to predict and publish reports before our competitors as well as meet client needs proactively. Market Research and Data Analytics (MRDA) 2. Provide pure play data analytics services for ad-hoc and long-term engagement projects of clients with market research layered into the analysis. We are the only global company to offer this combination one-stop service to clients. Redundancies generally seen by procuring data, analytics services from multiple vendors is overcome by our solution. Competitive Landscape Analysis (CLA) 3. Provide company financial analysis, market share analysis, competitive landscape insights and market movements to clients. This is one of the most important pain point and key request from majority of our clients, for which we use our proprietary methodologies to provide accurate CLA data. Accelerated Business Development (ABD) 4. Connect clients with their customers on a global scale by acting as an outsourced sales team on behalf of the client. This is a unique tri-party engagement model to benefit the client and their customer, and acts as a business development scale up at an international level. Market Intel Reports (MIR) 5. Provide one-stop venue with a searchable syndicate reports database from global companies available to clients. This augments our offerings exponentially and also assists in studying global client needs at an in-depth level.

Cancer Diagnostics Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

About IndustryARC IndustryARC strategy studies primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business. We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals.

We Work for You For IndustryARC, we value every customer equally. We only stay ready to help each client in the best way possible with a unique 24x365 support plan. We suggest looking at the following benefits of relying on Professional Business Consulting and Custom Market Research Services to realize the unique strategic gains on offer: 1. 2. 3. 4. 5. 6. 7.

Strengthen and improve organizational performance Strategic planning and analysing Adoption of newer and cost-effective technologies Become environmentally sustainable and profitable Improve their training and certification procedures. Planning for business automation. Project facilitation and management.

Cancer Diagnostics Market

010

Cancer Diagnostics Market

011